Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
Tracey G SimonDaniel E SingerYichi ZhangJulianna M MastrorilliAlexander CervoneElyse DiCesareKueiyu Joshua LinPublished in: Annals of internal medicine (2024)
National Institutes of Health.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- direct oral anticoagulants
- catheter ablation
- venous thromboembolism
- left atrial
- left atrial appendage
- public health
- healthcare
- heart failure
- mental health
- quality improvement
- percutaneous coronary intervention
- health information
- human health
- pulmonary embolism
- left ventricular